Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA clears IND for phase II study of TNX-102 SL

Aug. 7, 2020

Indivior begins first-in-human study of INDV-2000 for opioid dependence

July 9, 2020

Idorsia Pharmaceuticals identifies new Ox1-R and Ox2-R antagonists

June 4, 2020

Estrogen and dopamine

June 4, 2020

New alcohol risk genes in Caucasians

June 2, 2020

A new oxime that crosses the blood-brain barrier as a treatment for organo-phosphate poisoning

May 25, 2020

New MVP against SVMP

May 11, 2020

Antibiotics affect oxycodone effects

May 8, 2020

Platelets play role in Tylenol toxicity

April 30, 2020

Dopamine has epigenetic role in addiction

April 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...